Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 5 Comparison of CPG quality according to independent variables

From: Production and quality of clinical practice guidelines in Argentina (1994–2004): a cross-sectional study

  Median [Interquartile range] of standardized domain scores
  Scope Participation Rigour Clarity Applicability Independence
Diffusion year       
Period 1994–2000 (n = 22) 39% [40%] 15% [22%] 6% [10%] 42% [46%] 6% [17%] 0% [0%]
Year 2001 (n = 13) 33% [47%] 12% [29%] 10% [15%] 42% [46%] 0% [19%] 0% [0%]
Year 2002 (n = 19) 33% [28%] 8% [17%] 10% [15%] 50% [67%] 6% [6%] 0% [8%]
Year 2003 (n = 28) 39% [29%] 13% [13%] 12% [11%] 43% [40%] 11% [19%] 0% [0%]
Year 2004 (n = 19) 28% [39%] 13% [17%] 8% [14%] 33% [25%] 6% [11%] 0% [8%]
P value 0,66 0,89 0,28 0,68 0,52 0,72
Publication       
Published (n = 39) 39% [33%] 13% [46%] 10% [14%] 42% [29%] 6% [17%] 0% [0%]
Not Published (n = 62) 39% [33%] 10% [13%] 12% [14%] 44% [38%] 11% [17%] 0% [0%]
P value 0,93 0.76 0,23 0,40 0,24 0,43
Level of the Health System       
Macro (n = 12) 42% [44%] 13% [15%] 11% [13%] 61% [42%] 11% [18%] 0% [0%]
Meso (n = 25) 28% [31%] 8% [13%] 12% [12%] 37% [37%] 6% [11%] 0% [0%]
Micro (n = 49) 39% [32%] 13% [17%] 7% [14%] 41% [28%] 6% [11%] 0% [0%]
More than one level (n = 15) 39% [50%] 21% [13%] 12% [17%] 41% [37%] 6% [22%] 0% [0%]
P value 0,12 0,01 0,24 0,11 0,21 0,94
Guideline Scope       
National CPG (n = 74) 39% [33%] 13% [13%] 10% [15%] 42% [34%] 6% [18%] 0% [0%]
Regional/Local CPG (n = 27) 28% [25%] 8 % [13%] 12% [14%] 38% [38%] 6% [11% ] 0% [0%]
P value 0.11 0.12 0.24 0.52 0.35 0.4
CPG category       
Dx/treatment management (n = 71) 39% [28%] 13% [13%] 9% [14%] 42% [33%] 6% [17%] 0% [0%]
Prevention (n = 25) 39% [50%] 13% [19%] 9% [12%] 54% [35%] 6% [17%] 0% [0%]
P value 0,19 0,33 0,53 0,02 0,85 0,77